JPS5726625A - Sustained release type composite material entrapping medical enzyme and its preparation - Google Patents
Sustained release type composite material entrapping medical enzyme and its preparationInfo
- Publication number
- JPS5726625A JPS5726625A JP10146380A JP10146380A JPS5726625A JP S5726625 A JPS5726625 A JP S5726625A JP 10146380 A JP10146380 A JP 10146380A JP 10146380 A JP10146380 A JP 10146380A JP S5726625 A JPS5726625 A JP S5726625A
- Authority
- JP
- Japan
- Prior art keywords
- composite material
- medical
- protein
- sustained release
- type composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000790 Enzymes Proteins 0.000 title abstract 4
- 102000004190 Enzymes Human genes 0.000 title abstract 4
- 239000002131 composite material Substances 0.000 title abstract 3
- 238000013268 sustained release Methods 0.000 title abstract 2
- 239000012730 sustained-release form Substances 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 229940088598 enzyme Drugs 0.000 abstract 3
- 230000005865 ionizing radiation Effects 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 102000015790 Asparaginase Human genes 0.000 abstract 1
- 108010024976 Asparaginase Proteins 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- 102000007562 Serum Albumin Human genes 0.000 abstract 1
- 108010071390 Serum Albumin Proteins 0.000 abstract 1
- 108010092464 Urate Oxidase Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229960003272 asparaginase Drugs 0.000 abstract 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 abstract 1
- 108010074605 gamma-Globulins Proteins 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000001678 irradiating effect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 239000011369 resultant mixture Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10146380A JPS5726625A (en) | 1980-07-24 | 1980-07-24 | Sustained release type composite material entrapping medical enzyme and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10146380A JPS5726625A (en) | 1980-07-24 | 1980-07-24 | Sustained release type composite material entrapping medical enzyme and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5726625A true JPS5726625A (en) | 1982-02-12 |
| JPH0217527B2 JPH0217527B2 (enrdf_load_stackoverflow) | 1990-04-20 |
Family
ID=14301395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10146380A Granted JPS5726625A (en) | 1980-07-24 | 1980-07-24 | Sustained release type composite material entrapping medical enzyme and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5726625A (enrdf_load_stackoverflow) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5192743A (en) * | 1992-01-16 | 1993-03-09 | Genentech, Inc. | Reconstitutable lyophilized protein formulation |
| US5597802A (en) * | 1990-06-07 | 1997-01-28 | Genentech, Inc. | Method of formulating IGF-I with growth hormone |
| FR2810336A1 (fr) * | 2000-06-19 | 2001-12-21 | Prod Oenologiques J Laffort & | Procede de fabrication d'un produit de clarification ajustee d'un vin et produit de clarification obtenu |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5247912A (en) * | 1975-10-09 | 1977-04-16 | Minnesota Mining & Mfg | Solid serum albumin circles and its production |
-
1980
- 1980-07-24 JP JP10146380A patent/JPS5726625A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5247912A (en) * | 1975-10-09 | 1977-04-16 | Minnesota Mining & Mfg | Solid serum albumin circles and its production |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5597802A (en) * | 1990-06-07 | 1997-01-28 | Genentech, Inc. | Method of formulating IGF-I with growth hormone |
| US5681814A (en) * | 1990-06-07 | 1997-10-28 | Genentech, Inc. | Formulated IGF-I Composition |
| US5192743A (en) * | 1992-01-16 | 1993-03-09 | Genentech, Inc. | Reconstitutable lyophilized protein formulation |
| FR2810336A1 (fr) * | 2000-06-19 | 2001-12-21 | Prod Oenologiques J Laffort & | Procede de fabrication d'un produit de clarification ajustee d'un vin et produit de clarification obtenu |
| EP1167513A1 (fr) * | 2000-06-19 | 2002-01-02 | Produits Oenologiques J. Laffort & Cie (Société Anonyme) | Procédé de fabrication d'un produit de clarification ou de collage et produit obtenu |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0217527B2 (enrdf_load_stackoverflow) | 1990-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Seaman et al. | The surface structure of erythrocytes from some animal sources | |
| Alpar et al. | Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes | |
| ATE94553T1 (de) | Verfahren zur isolierung von langkettiger nukleinsaeure. | |
| ES2185218T5 (es) | Un plasma sanguineo aplicable universalmente. | |
| NL190268C (nl) | Werkwijze voor het bereiden van een bloedstollingsbevorderend preparaat op basis van humane proteinen. | |
| ES8106407A1 (es) | Procedimiento para el tratamiento de superficies hidrofobas | |
| JPS56135418A (en) | Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human | |
| ATE287210T1 (de) | Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen | |
| DE3680368D1 (de) | Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate. | |
| HRP931496A2 (en) | Process for the preparation of biological preparations not containing (active) viruses | |
| Morgenstern | Coated membranes in blood platelets | |
| US4537852A (en) | Process for the production of human urokinase | |
| JPS5726625A (en) | Sustained release type composite material entrapping medical enzyme and its preparation | |
| EP0152072A3 (en) | Pulsed light selective photolysis process for treatment of biological media and products made thereby | |
| GB2083826A (en) | Process for the production of human insulin | |
| ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
| AU678343B2 (en) | Method and composition for determining the immunological activity of bioactive substances | |
| JPS579709A (en) | Preparation of prolonged release type complex | |
| WO1991006322A1 (fr) | Support a commande magnetique a substance physiologiquement active et methode de realisation dudit support | |
| JPS57144983A (en) | Preparation of physiologically active substance | |
| US4624917A (en) | Process for the production of human T-cell growth factor | |
| DE3883044D1 (de) | Wirkstoff zur tumorbekaempfung. | |
| JPS579711A (en) | Preparation of prolonged release type complex | |
| Chang | Artificial cell including blood substitute and biomicroencapsulation: from ideas to applications | |
| BAUMAN | The role of binding proteins in substance-absorption processes |